Pharmacologically targeting intracellular allosteric sites of GPCRs for drug discovery

被引:8
作者
Zhang, Mingyang [1 ,2 ]
Lan, Xiaobing [1 ]
Li, Xiaolong [3 ]
Lu, Shaoyong [1 ,2 ]
机构
[1] Ningxia Med Univ, Sch Pharm, Yinchuan 750004, Ningxia, Peoples R China
[2] Shanghai Jiao Tong Univ, Med Chem & Bioinformat Ctr, Sch Med, Shanghai 200025, Peoples R China
[3] Naval Med Univ, Changhai Hosp, Dept Orthoped, Affiliated Hosp 1, Shanghai 200433, Peoples R China
基金
中国国家自然科学基金;
关键词
G-protein-coupled receptors (GPCRs); intracellular allosteric site; allostery; allosteric modulators; biased signaling; PROTEIN-COUPLED RECEPTOR; CHEMOKINE RECEPTOR; STRUCTURAL BASIS; ANTAGONISTS; CCR2; ACTIVATION; MODULATORS; MECHANISM; AGONIST; DISEASE;
D O I
10.1016/j.drudis.2023.103803
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
G-protein-coupled receptors (GPCRs) are a family of cell surface proteins that can sense a variety of extracellular stimuli and mediate multiple signaling transduction pathways involved in human physiology. Recent advances in GPCR structural biology have revealed a relatively conserved intracellular allosteric site in multiple GPCRs, which can be utilized to modulate receptors from the inside. This novel intracellular site partially overlaps with the G-protein and b-arrestin coupling sites, providing a novel avenue for biological intervention. Here, we review evidence available for GPCR structures complexed with intracellular small-molecule allosteric modulators, elucidating drug-target interactions and allosteric mechanisms. Moreover, we highlight the potential of intracellular allosteric modulators in achieving biased signaling, which provides insights into biased allosteric mechanisms.
引用
收藏
页数:10
相关论文
共 70 条
  • [1] Allosteric "beta-blocker" isolated from a DNA-encoded small molecule library
    Ahn, Seungkirl
    Kahsai, Alem W.
    Pani, Biswaranjan
    Wang, Qin-Ting
    Zhao, Shuai
    Wall, Alissa L.
    Strachan, Ryan T.
    Staus, Dean P.
    Wingler, Laura M.
    Sun, Lillian D.
    Sinnaeve, Justine
    Choi, Minjung
    Cho, Ted
    Xu, Thomas T.
    Hansen, Gwenn M.
    Burnett, Michael B.
    Lamerdin, Jane E.
    Bassoni, Daniel L.
    Gavino, Bryant J.
    Husemoen, Gitte
    Olsen, Eva K.
    Franch, Thomas
    Costanzi, Stefano
    Chen, Xin
    Lefkowitz, Robert J.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (07) : 1708 - 1713
  • [2] Structure of the vasopressin hormone-V2 receptor-β-arrestin1 ternary complex
    Bous, Julien
    Fouillen, Aurelien
    Orcel, Helene
    Trapani, Stefano
    Cong, Xiaojing
    Fontanel, Simon
    Saint-Paul, Julie
    Lai-Kee-Him, Josephine
    Urbach, Serge
    Sibille, Nathalie
    Sounier, Remy
    Granier, Sebastien
    Mouillac, Bernard
    Bron, Patrick
    [J]. SCIENCE ADVANCES, 2022, 8 (35)
  • [3] Stabilization of pre-existing neurotensin receptor conformational states by β-arrestin-1 and the biased allosteric modulator ML314
    Bumbak, Fabian
    Bower, James B.
    Zemmer, Skylar C.
    Inoue, Asuka
    Pons, Miquel
    Paniagua, Juan Carlos
    Yan, Fei
    Ford, James
    Wu, Hongwei
    Robson, Scott A.
    Bathgate, Ross A. D.
    Scott, Daniel J.
    Gooley, Paul R.
    Ziarek, Joshua J.
    [J]. NATURE COMMUNICATIONS, 2023, 14 (01)
  • [4] Danirixin: A Reversible and Selective Antagonist of the CXC Chemokine Receptor 2
    Busch-Petersen, Jakob
    Carpenter, Donald C.
    Burman, Miriam
    Foley, James
    Hunsberger, Gerald E.
    Kilian, David J.
    Salmon, Michael
    Mayer, Ruth J.
    Yonchuk, John G.
    Tal-Singer, Ruth
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 362 (02) : 338 - 346
  • [5] Chemokines and chemokine receptors in inflammatory bowel disease: Recent findings and future perspectives
    Camba-Gomez, Miguel
    Arosa, Laura
    Gualillo, Oreste
    Conde-Aranda, Javier
    [J]. DRUG DISCOVERY TODAY, 2022, 27 (04) : 1167 - 1175
  • [6] The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention
    Cambier, Seppe
    Gouwy, Mieke
    Proost, Paul
    [J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2023, 20 (03) : 217 - 251
  • [7] New Binding Sites, New Opportunities for GPCR Drug Discovery
    Chan, H. C. Stephen
    Li, Yi
    Dahoun, Thamani
    Vogel, Horst
    Yuan, Shuguang
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2019, 44 (04) : 312 - 330
  • [8] Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs
    Congreve, Miles
    Oswald, Christine
    Marshall, Fiona H.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2017, 38 (09) : 837 - 847
  • [9] Novel, acidic CCR2 receptor antagonists: Lead optimization
    Dasse, O. A.
    Evans, J. L.
    Zhai, H.-X.
    Zou, D.
    Kintigh, J. T.
    Chan, F.
    Hamilton, K.
    Hill, E.
    Eckman, J. B.
    Higgins, P. J.
    Volosov, A.
    Collart, P.
    Nicolas, J.-M.
    Kondru, R. K.
    Schwartz, C. E.
    [J]. LETTERS IN DRUG DESIGN & DISCOVERY, 2007, 4 (04) : 263 - 271
  • [10] Selective targeting of ligand-dependent and -independent signaling by GPCR conformation-specific anti-US28 intrabodies
    De Groof, Timo W. M.
    Bergkamp, Nick D.
    Heukers, Raimond
    Giap, Truc
    Bebelman, Maarten P.
    Goeij-de Haas, Richard
    Piersma, Sander R.
    Jimenez, Connie R.
    Garcia, K. Christopher
    Ploegh, Hidde L.
    Siderius, Marco
    Smit, Martine J.
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)